Skip to main content

Table 1 Clinical characteristics of participants at baseline

From: Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment

 

vMCI group N = 26

Control

N = 21

P

Male, N (%)

12(46.2%)

8(38.1%)

0.583

Age, years

71.04 ± 8.99

66.67 ± 9.19

0.108

Education, years

11.58 ± 3.18

11.62 ± 3. 49

0.966

Vascular risk factors

 BMI, kg/m2

26.02 ± 4.21

25.72 ± 2.42

0.774

 Hypertension, N(%)

26(100.0%)

11(52.4%)

<0.001

 Current Smoking, N(%)

4(15.4%)

3(14.3%)

0.623

 T2DM, N(%)

4(15.4%)

3(14.3%)

0.623

 Hyperlipidemia, N(%)

20(76.9%)

11(52.4%)

0.081

MTA scale

 Right(median (range))

0(0,1)

0(0,1)

0.085

 Left(median (range))

0(0,1)

0(0,1)

0.085

MoCA

23.04 ± 2.32

28.00 ± 1.22

<0.001

MMSE

26.31 ± 1.12

29.24 ± 0.70

<0.001

  1. Data are presented as mean ± SD, or counts (%)
  2. Abbreviations: N number of persons, vMCI vascular mild cognitive impairment, BMI body mass index, T2DM type 2 diabetes mellitus, MTA medial temporal lobe atrophy, MoCA Montreal Cognitive Assessment, MMSE mini-mental state examination